Head and neck cancer

• Phase 2, open-label, multicentre, single-arm study to evaluate the activity of the combination of EGFR inhibitors and c-MET inhibitors in pa … Pending
  2024-518892-72-00 4
• Phase II study of ezabenlimab in patients with PD-L1-positive head and neck cancer with residual disease detected by ctDNA after chemoradiot … Pending
  2025-523575-36-00 4 "Locally advanced head and neck squamous cell carcinoma (LA-H"
• A randomized, open-label, Phase III trial to assess the efficacy and safety of BupiZenge compared to lidocaine for pain associated with oral … Pending
  2025-524386-24-00 5
• A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 Recruiting
  2023-504445-31-00 4 2024-09-19 "Carcinoma, Head and Neck"
• Clinical trial evaluating the activity of zanidatamab for the treatment of patients with solid tumors with an alteration of the HER2 gene Recruiting
  2025-522169-31-00 4 2025-10-30 "Adult Patients with HER2-IHC3+ selected solid cancers (endom"
• A Phase 1/2, Multicenter, Open Label, Dose Escalation and Dose Expansion Study of JK06, a 5T4 Antibody Drug Conjugate, in Patients with Unre … Recruiting
  2024-512421-92-00 7 2025-10-14 "Unresectable, Locally Advanced or Metastatic Cancer"
• A Phase 3 study of NBTXR3 with or without cetuximab in LA-HNSCC Recruiting
  2024-520386-31-00 5 2025-09-22 "Locally Advanced Head & Neck Squamous Cell Carcinoma"
• A First-in-human Study to Evaluate the Safety and Anticancer Effect of Several Doses of TH9619 in Patients with Advanced Cancer (ODIN). Recruiting
  2024-519639-40-00 1 2025-08-18 "Solid tumors (including Non-Small Cell Lung Cancer (NSCLC), "
• First -in-Human Study of DS-3939a in Subjects with Advanced Solid Tumors Recruiting
  2023-507937-14-00 7 2025-03-25 "Metastatic Solid Tumor"
• The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Quality of Life Recruiting
  2024-513437-21-00 6 2024-10-02 "Cancer"
• Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors Recruiting
  2023-506604-18-00 1 2024-02-14 "Triple negative breast cancer"
• Study evaluating near-infrared imaging coupled with indocyanine green for intraoperative monitoring of resection margins in ENT surgery Recruiting
  2022-502737-26-00 4 2020-12-15 "epidermoid carcinoma"
• A Study of Sigvotatug Vedotin in Advanced Solid Tumors Recruiting
  2023-508469-34-00 1 2020-10-14 "Esophageal cancer"
• Adjuvant immunotherapy after salvage surgery in head and neck squamous cell carcinoma: phase 2 trial evaluating the efficacy and the toxicit … Recruiting
  2024-516810-39-00 4 2018-02-13 "Adjuvant therapy after salvage surgery of high risk recurren"
• A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours Recruitment ended
  2023-506228-10-00 7 2024-06-27 "Pancreatic Ductal Adenocarcinoma"
• ADP-A2M4CD8 in advanced cancers Recruitment ended
  2024-512864-71-00 3 2020-05-27 "Urothelial cancer Esophageal cancer Gastric cancer Non-smal"
• A study of TG4001 and avelumab cancer immunotherapies in advanced HPV-induced malignancies Recruitment ended
  2024-515119-23-00 9 2017-08-29 "Phase Ib and Phase II part 1: HPV-16 positive recurrent or m"
• Study comparing radiotherapy combined with cetuximab + Xevinapant (study drug) with radiotherapy combined with cetuximab + placebo in patien … Ended
  2022-502584-38-00 5 2023-12-12 "Locally advanced squamous cell carcinoma of the head and nec"
• Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors Ended
  2022-502867-39-00 1 2023-09-29 "Advanced solid tumors including non-small cell lung cancer ("
• A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies Ended
  2023-504400-29-00 1 2022-09-15 "Advanced malignancies."
• A Phase 1/2, Multicenter, Open Label, Dose Escalation & Dose Expansion Study of JK08 , an IL-15 Antibody Fusion Protein Targeting CTLA-4, Mo … Ended
  2024-511750-53-00 7 2022-09-08 "Unresectable Locally Advanced or Metastatic Cancer"
• A Phase 3 (Pivotal Stage) Study of NBTXR3 Activated by Investigator’s Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetux … Ended
  2024-513082-39-00 4 2022-04-26 "Locally Advanced Head & Neck Squamous Cell Carcinoma"
• Study comparing the standard administration of immunotherapy (IO) versus the same agent administered each three months in patients with loca … Ended
  2024-513707-14-00 5 2022-01-14 "Only patients with oncologic locally advanced or metastatic "
• A Phase 2 Study of ALX148 in Combination with Pembrolizumab in Patients with Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) Ended
  2023-508340-22-00 4 2021-08-11 "metastatic or unresectable, recurrent HNSCC"

Showing 1–24 of 29 trials